MOS
50
8
CNP
52
2
NTRS
64
-3
AVGO
38
-25
HP
42
-7
CCI
42
-2
FLR
42
-4
A
43
-3
DRI
53
-3
GS
75
-5
LEG
62
-2
ORCL
26
-4
GWW
65
-4
FITB
76
-4
LYB
23
-4
RSG
51
3
ZION
68
-3
AIV
41
-2
MDLZ
22
-16
FOX
70
-3
MOS
50
8
CNP
52
2
NTRS
64
-3
AVGO
38
-25
HP
42
-7
CCI
42
-2
FLR
42
-4
A
43
-3
DRI
53
-3
GS
75
-5
LEG
62
-2
ORCL
26
-4
GWW
65
-4
FITB
76
-4
LYB
23
-4
RSG
51
3
ZION
68
-3
AIV
41
-2
MDLZ
22
-16
FOX
70
-3
Financhill
Back

Foresight Autonomous Holdings Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
26

FRSX
Foresight Autonomous Holdings Ltd.

Last Price:
$1.84
Seasonality Move:
90.01%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.73
Seasonality Move:
11.58%
Sell
26
Foresight Autonomous Holdings Ltd. (FRSX) is a Sell

Is Foresight Autonomous Holdings Ltd. a Buy, Sell or Hold?

  • The current Foresight Autonomous Holdings Ltd. [FRSX] share price is $1.87. The Score for FRSX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • FRSX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FRSX Stock Price Chart

What is Foresight Autonomous Holdings Ltd.'s stock price today?

  • The Foresight Autonomous Holdings Ltd. share price today is $1.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRSX is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

FRSX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 37.1 Sell
Chaikin Money Flow: 5974 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.92 - 2.22) Sell
Bollinger Bands (100): (2.05 - 2.57) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

FRSX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.89 Sell
20-day SMA: 2.03 Sell
50-day SMA: 2.18 Sell
200-day SMA: 3.27 Sell
8-day EMA: 1.91 Sell
20-day EMA: 2.01 Sell
50-day EMA: 2.16 Sell
200-day EMA: 3.34 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Foresight Autonomous Holdings Ltd. Earnings Growth & FRSX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Foresight Autonomous Holdings Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):